ArticlePorcine health management2026
Seroprevalence of porcine coronavirus antibodies in Iberian pigs and wild boars from central-western Spain.
Article in Porcine health management, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Porcine coronaviruses (PoCoVs) are common etiological viral agents of enteric and respiratory disease in swine, but most epidemiological information derives from intensively managed herds. Data from outdoor systems and wildlife remain scarce, despite the potential role of free-range production and wildlife-livestock interactions in sustaining virus transmission. In southern Spain, the traditional Dehesa agroforestry system supports Iberian pigs that share space and resources with wild boars and other species, creating interfaces where cross-species circulation may occur. To address this gap, we assessed the seroprevalence of five PoCoVs, including porcine hemagglutinating encephalomyelitis virus (PHEV), porcine epidemic diarrhea virus (PEDV), porcine deltacoronavirus (PDCoV), transmissible gastroenteritis virus (TGEV), and porcine respiratory coronavirus (PRCV), in Iberian pigs and wild boars from central-western Spain. A total of 260 Iberian pig sera and 564 wild boar sera collected between 2016 and 2020 were tested using indirect ELISAs for PHEV, PEDV, and PDCoV and a blocking ELISA for PRCV/TGEV. Antibodies to PHEV were highly prevalent in Iberian pigs (68.0%) and detected at lower levels in wild boars (22.6%), a pattern consistent with endemic exposure in domestic pigs and sporadic circulation in wildlife. PEDV antibodies were identified in 8.5% of Iberian pigs and 2.8% of wild boars, with higher prevalence in pigs during 2016 followed by a sharp decline, suggesting past but not ongoing activity. PDCoV antibodies were rare overall (3.1% in pigs, 2.6% in wild boars) but reached 41.6% in pigs from Cáceres in 2017-2018, indicative of a localized event. PRCV antibodies were widespread in Iberian pigs (67.3%), with higher prevalence in Badajoz compared to Cáceres, while wild boars showed rising seropositivity in Ciudad Real/Toledo by 2022 (up to 33.3%). No TGEV antibodies were detected in either host population, supporting the predominance of PRCV in the region. These findings demonstrate that PHEV and PRCV are enzootic in free-range Iberian pigs, while PEDV and PDCoV circulate at low levels, and wild boars are more likely incidental than reservoir hosts. The detection of antibodies in the absence of clinical outbreaks underscores the silent nature of PoCoV circulation in extensive systems and highlights the importance of integrating wildlife-livestock interfaces into surveillance and biosecurity strategies in Mediterranean production landscapes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.